Perifosine in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00062387
Recruitment Status : Terminated (Administratively complete.)
First Posted : June 6, 2003
Last Update Posted : June 3, 2013
Information provided by (Responsible Party):
National Cancer Institute (NCI)